Clinical efficacy, safety and pharmacokinetic profile of EDP-938, a novel RSV n-inhibitor, in a healthy volunteer challenge study

Authors
Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2020
This article has no abstract
Epistemonikos ID: 458b3717298d3be8feea588c215e62b11617ed92
First added on: Feb 11, 2025